5.59Open5.59Pre Close0 Volume15 Open Interest72.00Strike Price0.00Turnover211.69%IV3.10%PremiumDec 20, 2024Expiry Date3.26Intrinsic Value100Multiplier1DDays to Expiry2.33Extrinsic Value100Contract SizeAmericanOptions Type0.6603Delta0.0383Gamma13.46Leverage Ratio-1.6885Theta0.0016Rho8.89Eff Leverage0.0165Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet